Skip to main content
Log in

Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Ewing's sarcoma family of tumors (EFT) contain reciprocal translocations, of which approximately 90% occur between the long arm of chromosomes 11 and 22, t(11;22)(q24;q12), resulting in the formation of chimeric proteins generated by a fusion of the EWS and FLI-1 genes. To determine if EWS-FLI-1 protein is responsible for the Ewing sarcoma phenotype we have used sequence-specific antisense oligodeoxynucleotides (ODN) to block its expression. We have evaluated a series of antisense ODN directed toward the breakpoint region in an effort to prevent translation of the fusion messenger RNA. ODN were first evaluated in a cell-free in vitro translation system. Exogenously added RNase H was found to be required for translation inhibition. ODN that showed complete inhibition of translation were electroporated into TC-32 cells, a EFT cell line. Fusion protein and EWS protein levels were evaluated by Western blot analysis. A 40—60% decrease in the fusion protein was observed in TC-32 cells with antisense ODN directed toward the breakpoint region. Cell viability was reduced with antisense sequences in TC-32 cells but not in a prostate cancer cell line. Since inhibition of t(11;22) gene product is correlated to effects on cell viability, reduction of the fusion protein may thus offer insight into the biology of EFT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akhtar S: Delivery strategies for antisense oligonucleotide therapeutics. CRC Press, Inc., Boca Raton, FL, 1995

    Google Scholar 

  2. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J: DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14: 3230, 1994

    Google Scholar 

  3. Bergan R, Connell Y, Fahmy B, Kyle E, Neckers L: Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure. Nucleic Acids Res 22: 2150, 1994

    Google Scholar 

  4. Bergan R, Connell Y, Fahmy B, Neckers L: Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic Acids Res 21: 3567, 1993

    Google Scholar 

  5. Bhat NK: P.T.S. Characterization and uses of monoclonal antibody derived against DNA binding domain of the ETS family of genes. Hybridoma 11: 277, 1992

    Google Scholar 

  6. Boiziau C, Larrouy B, Moreau S, Cazenave C, Shire D, Toulme JJ: Ribonuclease H-mediated inhibition of translation and reverse transcription by antisense oligodeoxynucleotides. Biochem Soc Trans 20: 764, 1992

    Google Scholar 

  7. Braun B, Frieden R, Lessnick S, May W, Denny C: Identification of Target Genes for the Ewing's Sarcoma EWS/FLI Fusion Protein by Representational Difference Analysis. Mol Cell Biol 15: 4623, 1995

    Google Scholar 

  8. Chen H, Gold L: Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity. Biochemistry 33: 8746, 1994

    Google Scholar 

  9. Damha MJ, Giannaris PA, Marfey P: Antisense L/D-oligodeoxynucleotide chimeras: nuclease stability, base-pairing properties, and activity at directing ribonuclease H. Biochemistry 33: 7877, 1994

    Google Scholar 

  10. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de JP, Rouleau G: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162, 1992

    Google Scholar 

  11. Dunn T, Praissman L, Hagag N, Viola MV: ERG gene is translocated in an Ewing's sarcoma cell line. Cancer Genet Cytogenet 76: 19, 1994

    Google Scholar 

  12. Kitada S, Miyashita T, Tanaka S, Reed JC: Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res Dev 3: 157, 1993

    Google Scholar 

  13. Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB: The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 269: 18216, 1994

    Google Scholar 

  14. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, Zucman J, Thomas G, Denny CT: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 90: 5752, 1993

    Google Scholar 

  15. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT: The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13: 7393, 1993

    Google Scholar 

  16. Peter M, Magdelenat H, Michon J, Melot T, Oberlin O, Zucker JM, Thomas G, Delattre O: Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. Br J Cancer 72: 96, 1995

    Google Scholar 

  17. Plougastel B, Zucman J, Peter M, Thomas G, Delattre O: Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 18: 609, 1993

    Google Scholar 

  18. Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES: Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Oncogene 8: 2167, 1993

    Google Scholar 

  19. Sakakura C, Yamaguchi-Iwai Y, Satake M, Bae SC, Takahashi A, Ogawa E, Hagiwara A, Takahashi T, Murakami A, Makino K: Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc Natl Acad Sci USA 91: 11723, 1994

    Google Scholar 

  20. Skorski T, Nieborowska-Skorska M, Nicolaides NC, Szczylik C, Iversen P, Iozzo RV, Zon G, Calabretta B: Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 91: 4504, 1994

    Google Scholar 

  21. Sorensen PH, Lessnick SL, Lopez TD, Liu XF, Triche TJ, Denny CT: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 6: 146, 1994

    Google Scholar 

  22. Toretsky JA, Neckers L, Wexler LH: Detection of (11;22) (q24;q12) translocation-bearing cells in peripheral blood progenitor cells of patients with Ewing's sarcoma family of tumors. J Natl Cancer Inst 87: 385, 1995

    Google Scholar 

  23. Whang PJ, Triche TJ, Knutsen T, Miser J, Kao SS, Tsai S, Israel MA: Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 21: 185, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Toretsky, J.A., Connell, Y., Neckers, L. et al. Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides. J Neurooncol 31, 09–16 (1997). https://doi.org/10.1023/A:1005716926800

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005716926800

Navigation